Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.

[1]  P. Bianco,et al.  Skeletal stem cells , 2015, Development.

[2]  J. Christian,et al.  Sickle cell disease and perioperative considerations: review and retrospective report. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[3]  A. Caplan,et al.  Mesenchymal Stem Cells in Tissue Repair , 2013, Front. Immunol..

[4]  D. Phinney.  Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy , 2012, Journal of cellular biochemistry.

[5]  Philippe Bierling,et al.  In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells. , 2012, Tissue engineering. Part A.

[6]  J. Hui,et al.  Improved mesenchymal stem cells attachment and in vitro cartilage tissue formation on chitosan-modified poly(L-lactide-co-epsilon-caprolactone) scaffold. , 2012, Tissue engineering. Part A.

[7]  F. Galactéros,et al.  The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease. , 2012, The Journal of bone and joint surgery. American volume.

[8]  J. García-Sancho,et al.  Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study , 2011, Transplantation.

[9]  P. Kasten,et al.  Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. , 2011, European cells & materials.

[10]  Y. St-Pierre,et al.  Bidirectional interactions between bone metabolism and hematopoiesis. , 2011, Experimental hematology.

[11]  C. Jorgensen,et al.  Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology , 2011, Stem Cell Research & Therapy.

[12]  J. Fischer,et al.  Bridging the gap: Bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[13]  A. Bolarinwa,et al.  Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease , 2009, International Orthopaedics.

[14]  P. Hernigou,et al.  Multifocal Joint Osteonecrosis in Sickle Cell Disease , 2009, The open orthopaedics journal.

[15]  P. Hernigou,et al.  Percutaneous Implantation of Autologous Bone Marrow Osteoprogenitor Cells as Treatment of Bone Avascular Necrosis Related to Sickle Cell Disease , 2008, The open orthopaedics journal.

[16]  P. Robey,et al.  Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. , 2007, Experimental hematology.

[17]  A. Cometa,et al.  Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute , 2007, Journal of cellular physiology.

[18]  D. Bachir,et al.  The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. , 2006, The Journal of bone and joint surgery. American volume.

[19]  X. Holy,et al.  Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications , 2005, Journal of cellular physiology.

[20]  N. Fisk,et al.  Fetal stem cells. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[21]  S. Both,et al.  Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells , 2004, Journal of materials science. Materials in medicine.

[22]  D. Prockop,et al.  An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. , 2004, Analytical biochemistry.

[23]  Celso Matos,et al.  Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. , 2004, The Journal of bone and joint surgery. American volume.

[24]  Ching-Chuan Jiang,et al.  Multipotential Mesenchymal Stem Cells from Femoral Bone Marrow Near the Site of Osteonecrosis , 2003, Stem cells.

[25]  P. Hernigou,et al.  Treatment of Osteonecrosis With Autologous Bone Marrow Grafting , 2002, Clinical orthopaedics and related research.

[26]  P. Robey,et al.  EFFECT OF SERUM ON HUMAN BONE MARROW STROMAL CELLS: EX VIVO EXPANSION AND IN VIVO BONE FORMATION , 2000, Transplantation.

[27]  E. Vichinsky,et al.  The perioperative complication rate of orthopedic surgery in sickle cell disease: Report of the national sickle cell surgery study group , 1999, American journal of hematology.

[28]  R. Cancedda,et al.  Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. , 1999, Experimental hematology.

[29]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  P. Hernigou,et al.  Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. , 1999, The Journal of bone and joint surgery. British volume.

[31]  P. Bianco,et al.  Diseases of Bone and the Stromal Cell Lineage , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[33]  N. Uike,et al.  Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells. , 1994, Experimental hematology.

[34]  L. Sleeper,et al.  Sickle cell disease as a cause of osteonecrosis of the femoral head. , 1991, The New England journal of medicine.

[35]  Graham R Serjeant,et al.  Sickle-cell disease , 1984, The Lancet.

[36]  M. Marcacci,et al.  Bone regeneration with mesenchymal stem cells. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[37]  Casey K Chan,et al.  Stem cell homing in musculoskeletal injury. , 2011, Biomaterials.

[38]  Philippe Bierling,et al.  Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. , 2010, Biomaterials.

[39]  P. Hernigou,et al.  Cell therapy of hip osteonecrosis with autologous bone marrow grafting , 2009, Indian journal of orthopaedics.

[40]  P. Bianco,et al.  Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. , 2009, Stem cell research.

[41]  Wen-jian Zhang,et al.  Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head. , 2008, Orthopedics.

[42]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[43]  A. Marti-Carvajal,et al.  Treatment for avascular necrosis of bone in people with sickle cell disease. , 2004, The Cochrane database of systematic reviews.

[44]  A. Carr,et al.  Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. , 1998, Scandinavian journal of rheumatology.

[45]  Rm,et al.  Sickle cell disease , 1996 .

[46]  I. M. Vertkin,et al.  Risk Factors , 2007, Morality and Ethics at War.

[47]  C Argote-Olivera,et al.  [Sickle-cell anemia]. , 1977, La Prensa medica mexicana.